NASDAQ:ASND

Ascendis Pharma A/s Stock Insider Trading

etoro logo Buy ASND
*Your capital is at risk
$243.91
-7.16 (-2.85%)
At Close: Jul 31, 2026

Ascendis Pharma A/S Stock Insider Power

Based on the 87 latest insides trades, we have calculated the insider power to be positive at 81.21. In total, the insiders bought 1.6M and sold 19.46K ASND shares in the last 87 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 87 transactions)
81.21
Buy 1.6M shares
Sell 19.46K shares
99% Buy Activity
Moderate Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 18, 2026
Buy
Warrants
Pedersen Anni Lotte Kirstine Sonderbjerg
EVP & Chief Admin Officer
Officer 27 000
Value: $2.92M
Mar 18, 2026
Buy
Warrants
Pedersen Anni Lotte Kirstine Sonderbjerg
EVP & Chief Admin Officer
Officer 22 755
Value: $4.01M
Mar 18, 2026
Buy
Warrants
Pedersen Anni Lotte Kirstine Sonderbjerg
EVP & Chief Admin Officer
Officer 14 504
Value: $2.03M
Mar 18, 2026
Buy
Restricted Stock Units
Pedersen Anni Lotte Kirstine Sonderbjerg
EVP & Chief Admin Officer
Officer 9 552
Value: $2.17M
Mar 18, 2026
Buy
Ordinary Shares
Morrison Lisa
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Warrants
Morrison Lisa
Director
Director 5 105
Value: $116.2K
Mar 18, 2026
Buy
Warrants
Morrison Lisa
Director
Director 5 000
Value: $185.9K
Mar 18, 2026
Buy
Warrants
Morrison Lisa
Director
Director 13 000
Value: $808.2K
Mar 18, 2026
Buy
Warrants
Morrison Lisa
Director
Director 7 500
Value: $810.0K
Mar 18, 2026
Buy
Warrants
Morrison Lisa
Director
Director 6 420
Value: $1.13M
Mar 18, 2026
Buy
Warrants
Morrison Lisa
Director
Director 3 053
Value: $426.4K
Mar 18, 2026
Buy
Restricted Stock Units
Morrison Lisa
Director
Director 1 930
Value: $438.9K
Mar 18, 2026
Buy
Ordinary Shares
Holtug Lars
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Warrants
Holtug Lars
Director
Director 35 000
Value: $2.14M
Mar 18, 2026
Buy
Warrants
Holtug Lars
Director
Director 7 500
Value: $810.0K
Mar 18, 2026
Buy
Warrants
Holtug Lars
Director
Director 6 420
Value: $1.13M
Mar 18, 2026
Buy
Warrants
Holtug Lars
Director
Director 3 053
Value: $426.4K
Mar 18, 2026
Buy
Restricted Stock Units
Holtug Lars
Director
Director 1 930
Value: $438.9K
Mar 18, 2026
Buy
Ordinary Shares
Fairey William
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Sprogoe Kennett
See Remarks
Officer 0
Value: $0
Mar 18, 2026
Buy
Warrants
Sprogoe Kennett
See Remarks
Officer 5 313
Value: $197.5K
Mar 18, 2026
Buy
Warrants
Sprogoe Kennett
See Remarks
Officer 45 000
Value: $2.80M
Mar 18, 2026
Buy
Warrants
Sprogoe Kennett
See Remarks
Officer 27 000
Value: $2.92M
Mar 18, 2026
Buy
Warrants
Sprogoe Kennett
See Remarks
Officer 22 755
Value: $4.01M
Mar 18, 2026
Buy
Warrants
Sprogoe Kennett
See Remarks
Officer 14 504
Value: $2.03M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ASCENDIS PHARMA A/S
Ascendis Pharma A/S
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE